Global RNA Based Therapeutics Market 2024-2028

Global RNA Based Therapeutics Market 2024-2028


RNA Based Therapeutics Market 2024-2028

The RNA based therapeutics market is forecasted to grow by USD 1268.2 mn during 2023-2028, accelerating at a CAGR of 5.54% during the forecast period. The report on the RNA based therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing investment and funding in RNA based therapeutics, expansion of RNA based therapeutics through government authorization, and rising incidence of chronic and infectious diseases.

Technavio's RNA based therapeutics market is segmented as below:

By Type
  • mRNA therapeutics
  • Antisense oligonucleotide (ASO) therapeutics
  • RNA interference (RNAi) therapeutics
  • Others
By Route Of Administration
  • Intravenous (IV)
  • Subcutaneous (SC)
  • Intramuscular (IM)
By Geographical Landscape
  • Europe
  • North America
  • Asia
  • Rest of World (ROW)
This study identifies the increasing collaborations and partnerships as one of the prime reasons driving the RNA based therapeutics market growth during the next few years. Also, developments in gene editing technologies and advancements in drug delivery systems will lead to sizable demand in the market.

The report on the RNA based therapeutics market covers the following areas:
  • RNA based therapeutics market sizing
  • RNA based therapeutics market forecast
  • RNA based therapeutics market industry analysis
The vendors analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading RNA based therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc., Ascidian Therapeutics Inc, AstraZeneca PLC, Beam Therapeutics Inc., Benitec Biopharma Inc., Biogen Inc., BioNTech SE, BioSpace, Circular Genomics Inc., CureVac AG, Esperovax, Gennova Biopharmaceuticals Ltd, Ionis Pharmaceuticals Inc., Moderna Inc., Novartis AG, Novo Nordisk AS, Omega Therapeutics Inc., Sarepta Therapeutics Inc., Silence Therapeutics PLC, and Tevard Biosciences. Also, the RNA based therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value Chain Analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global RNA Based Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global RNA Based Therapeutics Market 2018 - 2022 ($ million)
5.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
5.3 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global RNA Based Therapeutics Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 mRNA therapeutics - Market size and forecast 2023-2028
Chart on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
Data Table on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
Chart on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
Data Table on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
8.4 Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028
Chart on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
Data Table on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
Chart on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
Data Table on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
8.5 RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028
Chart on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
Data Table on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
Chart on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
Data Table on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
8.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Intravenous (IV) - Market size and forecast 2023-2028
Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
9.4 Subcutaneous (SC) - Market size and forecast 2023-2028
Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
9.5 Intramuscular (IM) - Market size and forecast 2023-2028
Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.4 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.12 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
11.13 Italy - Market size and forecast 2023-2028
Chart on Italy - Market size and forecast 2023-2028 ($ million)
Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Chart on Italy - Year-over-year growth 2023-2028 (%)
Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.14 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
11.15 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
11.16 Singapore - Market size and forecast 2023-2028
Chart on Singapore - Market size and forecast 2023-2028 ($ million)
Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
Chart on Singapore - Year-over-year growth 2023-2028 (%)
Data Table on Singapore - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals Inc. - Overview
Alnylam Pharmaceuticals Inc. - Product / Service
Alnylam Pharmaceuticals Inc. - Key offerings
SWOT
14.5 Arbutus Biopharma Corp.
Arbutus Biopharma Corp. - Overview
Arbutus Biopharma Corp. - Product / Service
Arbutus Biopharma Corp. - Key offerings
SWOT
14.6 Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. - Overview
Arcturus Therapeutics Holdings Inc. - Product / Service
Arcturus Therapeutics Holdings Inc. - Key offerings
SWOT
14.7 Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc. - Overview
Arrowhead Pharmaceuticals Inc. - Product / Service
Arrowhead Pharmaceuticals Inc. - Key offerings
SWOT
14.8 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
14.9 Benitec Biopharma Inc.
Benitec Biopharma Inc. - Overview
Benitec Biopharma Inc. - Product / Service
Benitec Biopharma Inc. - Key offerings
SWOT
14.10 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
SWOT
14.11 BioNTech SE
BioNTech SE - Overview
BioNTech SE - Product / Service
BioNTech SE - Key offerings
SWOT
14.12 CureVac AG
CureVac AG - Overview
CureVac AG - Product / Service
CureVac AG - Key offerings
SWOT
14.13 Gennova Biopharmaceuticals Ltd
Gennova Biopharmaceuticals Ltd - Overview
Gennova Biopharmaceuticals Ltd - Product / Service
Gennova Biopharmaceuticals Ltd - Key offerings
SWOT
14.14 Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc. - Overview
Ionis Pharmaceuticals Inc. - Product / Service
Ionis Pharmaceuticals Inc. - Key news
Ionis Pharmaceuticals Inc. - Key offerings
SWOT
14.15 Moderna Inc.
Moderna Inc. - Overview
Moderna Inc. - Product / Service
Moderna Inc. - Key offerings
SWOT
14.16 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key news
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
SWOT
14.17 Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc. - Overview
Sarepta Therapeutics Inc. - Product / Service
Sarepta Therapeutics Inc. - Key offerings
SWOT
14.18 Silence Therapeutics plc
Silence Therapeutics plc - Overview
Silence Therapeutics plc - Product / Service
Silence Therapeutics plc - Key offerings
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2023 and 2028
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value Chain Analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits24: Historic Market Size - Data Table on Global RNA Based Therapeutics Market 2018 - 2022 ($ million)
Exhibits25: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits26: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits29: Five forces analysis - Comparison between 2023 and 2028
Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits35: Chart on Market condition - Five forces 2023 and 2028
Exhibits36: Chart on Type - Market share 2023-2028 (%)
Exhibits37: Data Table on Type - Market share 2023-2028 (%)
Exhibits38: Chart on Comparison by Type
Exhibits39: Data Table on Comparison by Type
Exhibits40: Chart on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Type ($ million)
Exhibits57: Data Table on Market opportunity by Type ($ million)
Exhibits58: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits59: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits60: Chart on Comparison by Route of Administration
Exhibits61: Data Table on Comparison by Route of Administration
Exhibits62: Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibits71: Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibits72: Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibits74: Market opportunity by Route of Administration ($ million)
Exhibits75: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits117: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits118: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits119: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits120: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits121: Chart on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits122: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits123: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibits124: Data Table on Italy - Year-over-year growth 2023-2028 (%)
Exhibits125: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits126: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits127: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits128: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits129: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits133: Chart on Singapore - Market size and forecast 2023-2028 ($ million)
Exhibits134: Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
Exhibits135: Chart on Singapore - Year-over-year growth 2023-2028 (%)
Exhibits136: Data Table on Singapore - Year-over-year growth 2023-2028 (%)
Exhibits137: Market opportunity By Geographical Landscape ($ million)
Exhibits138: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits139: Impact of drivers and challenges in 2023 and 2028
Exhibits140: Overview on criticality of inputs and factors of differentiation
Exhibits141: Overview on factors of disruption
Exhibits142: Impact of key risks on business
Exhibits143: Companies covered
Exhibits144: Company ranking index
Exhibits145: Matrix on companies position and classification
Exhibits146: Alnylam Pharmaceuticals Inc. - Overview
Exhibits147: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibits148: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits149: SWOT
Exhibits150: Arbutus Biopharma Corp. - Overview
Exhibits151: Arbutus Biopharma Corp. - Product / Service
Exhibits152: Arbutus Biopharma Corp. - Key offerings
Exhibits153: SWOT
Exhibits154: Arcturus Therapeutics Holdings Inc. - Overview
Exhibits155: Arcturus Therapeutics Holdings Inc. - Product / Service
Exhibits156: Arcturus Therapeutics Holdings Inc. - Key offerings
Exhibits157: SWOT
Exhibits158: Arrowhead Pharmaceuticals Inc. - Overview
Exhibits159: Arrowhead Pharmaceuticals Inc. - Product / Service
Exhibits160: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibits161: SWOT
Exhibits162: AstraZeneca Plc - Overview
Exhibits163: AstraZeneca Plc - Product / Service
Exhibits164: AstraZeneca Plc - Key news
Exhibits165: AstraZeneca Plc - Key offerings
Exhibits166: SWOT
Exhibits167: Benitec Biopharma Inc. - Overview
Exhibits168: Benitec Biopharma Inc. - Product / Service
Exhibits169: Benitec Biopharma Inc. - Key offerings
Exhibits170: SWOT
Exhibits171: Biogen Inc. - Overview
Exhibits172: Biogen Inc. - Product / Service
Exhibits173: Biogen Inc. - Key news
Exhibits174: Biogen Inc. - Key offerings
Exhibits175: SWOT
Exhibits176: BioNTech SE - Overview
Exhibits177: BioNTech SE - Product / Service
Exhibits178: BioNTech SE - Key offerings
Exhibits179: SWOT
Exhibits180: CureVac AG - Overview
Exhibits181: CureVac AG - Product / Service
Exhibits182: CureVac AG - Key offerings
Exhibits183: SWOT
Exhibits184: Gennova Biopharmaceuticals Ltd - Overview
Exhibits185: Gennova Biopharmaceuticals Ltd - Product / Service
Exhibits186: Gennova Biopharmaceuticals Ltd - Key offerings
Exhibits187: SWOT
Exhibits188: Ionis Pharmaceuticals Inc. - Overview
Exhibits189: Ionis Pharmaceuticals Inc. - Product / Service
Exhibits190: Ionis Pharmaceuticals Inc. - Key news
Exhibits191: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits192: SWOT
Exhibits193: Moderna Inc. - Overview
Exhibits194: Moderna Inc. - Product / Service
Exhibits195: Moderna Inc. - Key offerings
Exhibits196: SWOT
Exhibits197: Novo Nordisk AS - Overview
Exhibits198: Novo Nordisk AS - Business segments
Exhibits199: Novo Nordisk AS - Key news
Exhibits200: Novo Nordisk AS - Key offerings
Exhibits201: Novo Nordisk AS - Segment focus
Exhibits202: SWOT
Exhibits203: Sarepta Therapeutics Inc. - Overview
Exhibits204: Sarepta Therapeutics Inc. - Product / Service
Exhibits205: Sarepta Therapeutics Inc. - Key offerings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings